Medicare Enrolled
Dr. Michael Annabi, MD
Internal Medicine · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Annabi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Annabi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Annabi
Dr. Michael Annabi is an internal medicine specialist in El Paso, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Annabi performed 5,118 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Annabi received a total of $208,206 from 68 pharmaceutical and/or device companies across 1130 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Annabi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in TX
$208,206 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,118
Medicare services
Top 7% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
3,048 | $62 | $102 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
763 | $59 | $101 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
669 | $101 | $193 |
| Oxygen chamber therapy management This code covers the professional management and oversight of a patient undergoing oxygen chamber therapy. It involves monitoring the patient's response and adjusting the treatment plan as needed. |
85 | $78 | $250 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
83 | $63 | $101 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
67 | $10 | $34 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
65 | $1 | $5 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
62 | $126 | $151 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
60 | $0 | $10 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
54 | $165 | $315 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
32 | $16 | $50 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
29 | $16 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
24 | $1 | $15 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
23 | $22 | $30 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
23 | $29 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $95 | $149 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
15 | $3 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$208,206
Total received (2018-2024)
Avg $29,744/year across 7 years
Top 1% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,130
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,701
2023
$20,499
2022
$30,749
2021
$32,129
2020
$26,585
2019
$41,121
2018
$40,422
Payments by company (2024)
Novo Nordisk Inc
$10,841
Lilly USA, LLC
$2,689
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,020
AstraZeneca Pharmaceuticals LP
$242
Phathom Pharmaceuticals, Inc.
$152
Bayer Healthcare Pharmaceuticals Inc.
$146
Janssen Pharmaceuticals, Inc
$88
Xeris Pharmaceuticals, Inc.
$87
Dexcom, Inc.
$79
ABBVIE INC.
$71
Abbott Laboratories
$48
Merck Sharp & Dohme LLC
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Novartis Pharmaceuticals Corporation
$23
Corcept Therapeutics
$21
Amgen Inc.
$18
Astellas Pharma US Inc
$17
PFIZER INC.
$17
E.R. Squibb & Sons, L.L.C.
$16
Averitas Pharma Inc.
$16
SCPHARMACEUTICALS INC.
$16
Smith+Nephew, Inc.
$14
BETA BIONICS, INC.
$11
Top 3 companies account for 93.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$88,091
Boehringer Ingelheim Pharmaceuticals, Inc.
$38,261
SANOFI-AVENTIS U.S. LLC
$30,943
AstraZeneca Pharmaceuticals LP
$29,968
Lilly USA, LLC
$12,425
PFIZER INC.
$1,337
Janssen Pharmaceuticals, Inc
$980
Abbott Laboratories
$903
Astellas Pharma US Inc
$389
Novartis Pharmaceuticals Corporation
$356
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$280
Amarin Pharma Inc.
$276
Amgen Inc.
$267
Merck Sharp & Dohme Corporation
$248
Takeda Pharmaceuticals U.S.A., Inc.
$231
Bayer Healthcare Pharmaceuticals Inc.
$209
Dexcom, Inc.
$173
Xeris Pharmaceuticals, Inc.
$172
Phathom Pharmaceuticals, Inc.
$152
Medtronic, Inc.
$151
Allergan, Inc.
$139
GlaxoSmithKline, LLC.
$137
Biohaven Pharmaceuticals, Inc.
$123
Allergan Inc.
$121
Bayer HealthCare Pharmaceuticals Inc.
$117
Corcept Therapeutics
$117
Insulet Corporation
$116
Radius Health, Inc.
$110
SCILEX PHARMACEUTICALS INC.
$107
AbbVie Inc.
$95
ABBVIE INC.
$87
Teva Pharmaceuticals USA, Inc.
$77
Biohaven Pharmaceutical Holding Company Ltd.
$72
Merck Sharp & Dohme LLC
$70
Boston Scientific Corporation
$68
UCB, Inc.
$64
E.R. Squibb & Sons, L.L.C.
$60
Flexion Therapeutics, Inc.
$53
IRONWOOD PHARMACEUTICALS, INC
$52
AbbVie, Inc.
$41
Gilead Sciences, Inc.
$38
DEXCOM, INC.
$37
Biogen, Inc.
$36
Jazz Pharmaceuticals Inc.
$34
ARBOR PHARMACEUTICALS, INC.
$31
Kowa Pharmaceuticals America, Inc.
$30
Pharming Healthcare, Inc.
$28
Inspire Medical Systems, Inc.
$24
Eisai Inc.
$21
Duchesnay USA Incorporated
$20
Ultragenyx Pharmaceutical Inc.
$20
Horizon Therapeutics plc
$20
Vertical Pharmaceuticals, LLC
$20
Becton, Dickinson and Company
$18
Mallinckrodt Hospital Products Inc.
$18
Vifor Pharma, Inc.
$18
Averitas Pharma Inc.
$16
SCPHARMACEUTICALS INC.
$16
Smith+Nephew, Inc.
$14
Exact Sciences Corporation
$13
Purdue Pharma L.P.
$13
Shire North American Group Inc
$13
Philips Electronics North America Corporation
$12
Scilex Pharmaceuticals Inc.
$12
Avion Pharmaceuticals
$12
Octapharma USA, Inc.
$11
Melinta Therapeutics, Inc.
$11
BETA BIONICS, INC.
$11
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · ADUHELM · ADVAIR · ADVATE · AIMOVIG · AIRSUPRA · AJOVY · ANORO ELLIPTA · AVYCAZ · Aimovig · Allure Quadra RF CRT Pacemaker · Amitiza · BD Nano · BELSOMRA · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · Baxdela · CHANTIX · COLLAGENASE SANTYL · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · COREVALVE EVOLUT R · CREON · CRT-Ds · Cologuard Collection Kit · Confirm Rx · Crysvita · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVUSHELD · Enbrel · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FUROSCIX · FreeStyle Libre · FreeStyle Libre 2 · GATTEX · GVOKE HYPOPEN · GVOKE PFS · Gloperba · Horizant · Humira · INSPIRE · INVOKANA · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LANTUS · LINZESS · LOKELMA · LORZONE · LYRICA · Linzess · Livalo · MOUNJARO · MOVANTIK · MYRBETRIQ · Myrbetriq · NAMZARIC · NUCALA · NURTEC ODT · NUWIQ · Nubeqa · OFEV · Omnipod · Osphena · Otezla · Ozempic · PRALUENT · PREMARIN · Prolia · QUTENZA · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RAYOS · RUCONEST · RYBELSUS · Repatha · Rybelsus · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SUNOSI · SYMBICORT · SYNJARDY · TAKHZYRO · TEFLARO · TERLIVAZ · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tendril Pacing Lead · Tresiba · Tymlos · UBRELVY · Uloric · Unify Assura CRT Defibrillator · VERQUVO · VIBERZI · VONVENDI · VOQUEZNA · VRAYLAR · Vascepa · Veltassa · Veozah · Victoza · Vimpat · WATCHMAN Access System · WATCHMAN FLX · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZERBAXA · ZTLido · Zilretta · iLet Bionic Pancreas
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
288
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
RIO VISTA BEHAVIORAL HEALTH
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Annabi is a clinical cardiology specialist, with above-average Medicare volume (top 7% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Annabi experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Annabi performed 3,048 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Annabi receive payments from pharmaceutical companies?
Yes. Dr. Annabi received a total of $208,206 from 68 companies across 1,130 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Annabi's costs compare to other internal medicine physicians in El Paso?
Dr. Annabi's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Annabi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in El Paso
Browse internal medicine physicians in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology